Bind Therapeutics (BIND) Stock: Heres What You Need To Know

Bind Therapeutics (NASDAQ:BIND) On July 1, 2016 Bind Therapeutics announced that it had agreed to a stalking horse bid from Pfizer. The company said that it had filed a motion in court for a purchase agreement whereby Pfizer would acquire Bind’s assets. Investors greatly cheered this news and the stock nearly doubled to 0.78 cents … Read more